Lazzerini, L., Jöhrens, K., Sehouli, J., & Cichon, G. (2020). Favorable therapeutic response after anti-Mesothelin antibody–drug conjugate treatment requires high expression of Mesothelin in tumor cells. Arch Gynecol Obstet.
Chicago Style CitationLazzerini, Lea, Korinna Jöhrens, Jalid Sehouli, i Günter Cichon. "Favorable Therapeutic Response After Anti-Mesothelin Antibody–drug Conjugate Treatment Requires High Expression of Mesothelin in Tumor Cells." Arch Gynecol Obstet 2020.
Cita MLALazzerini, Lea, Korinna Jöhrens, Jalid Sehouli, i Günter Cichon. "Favorable Therapeutic Response After Anti-Mesothelin Antibody–drug Conjugate Treatment Requires High Expression of Mesothelin in Tumor Cells." Arch Gynecol Obstet 2020.
Atenció: Aquestes cites poden no estar 100% correctes.